炎症性肠病相关恶性肿瘤的影像表现:模式、陷阱与要点
本文综述炎症性肠病患者胃肠道及肝胆系统恶性肿瘤的影像表现,重点讨论克罗恩病相关小肠腺癌、结肠炎相关结直肠癌、瘘管相关肛周恶性肿瘤及原发性硬化性胆管炎相关胆管癌。文章强调恶性肿瘤常表现为偏离炎症性疾病预期的影像行为,而非单一特征,并介绍弥散加权MRI、双能CT、影像组学、弹性成像及FAPI成像等新兴技术。
要点
- 识别IBD相关恶性肿瘤重在纵向对比,关注与炎症预期行为不符的微小形态变化。
- 影像在发现肠镜评估受限节段的病变及判断透壁和肠外病变中起补充作用。
- 结构式报告应纳入对可疑恶变特征的描述,以促进多学科沟通和进一步干预。
核心结论
- IBD相关恶性肿瘤的影像诊断主要依据病变偏离炎症性疾病预期影像行为的纵向变化,而非单一征象。
- 仔细的纵向对比和多学科关联对于早期检出IBD相关恶性肿瘤至关重要。
研究设计与样本
- 综述性文章,检索范围为炎症性肠病相关胃肠道及肝胆系统恶性肿瘤影像表现的相关文献。
- 涵盖小肠、结肠、直肠、肛周区域及肝胆系统的影像学表现,并讨论诊断陷阱、鉴别要点及结构式报告。
- 同时讨论弥散加权MRI、双能CT、影像组学、弹性成像及FAPI成像等新兴定量和分子影像技术。
关键影像表现/征象
- 恶性转化常表现为随时间推移偏离炎症性疾病预期影像行为的微小形态变化。
- 影像表现常与慢性炎症改变重叠,单一定性征象在鉴别恶性转化中价值有限。
- 影像可评估肠镜无法充分观察或难以到达节段中的病变,并显示透壁及肠外病变。
临床应用与阅片要点
- 阅片时应重点进行纵向影像对比,识别与炎症预期行为不一致的形态学变化。
- 发现可疑恶变特征时,应在报告中提示加强内镜监测、组织取样或进一步干预。
- 需警惕慢性炎症、纤维化与恶性病变在常规影像上的表现重叠,避免漏诊或过度诊断。
局限性
- 炎症性肠病相关恶性病变与慢性炎症的影像表现存在明显重叠,鉴别诊断具有挑战性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Patients with inflammatory bowel disease (IBD) are at increased risk of gastrointestinal and hepatobiliary malignancies arising in the setting of chronic inflammation, dysplasia, stricturing disease, and fistulizing complications. Although endoscopic surveillance remains the cornerstone for dysplasia detection, imaging plays an increasingly important complementary role in identifying invasive malignancy, evaluating transmural and extra-intestinal disease, and detecting lesions in segments inaccessible or poorly amenable to endoscopic assessment. Distinguishing malignant transformation from chronic inflammatory change remains challenging because imaging findings frequently overlap. In practice, malignancy is often suggested less by a single defining feature than by deviation from the expected imaging behaviour of inflammatory disease over time. This review summarizes the imaging manifestations of malignancy in IBD across the small bowel, colon, rectum, perianal region, and hepatobiliary system, with emphasis on Crohn's disease-associated small bowel adenocarcinoma, colitis-associated colorectal carcinoma, fistula-associated anorectal malignancy, and cholangiocarcinoma in primary sclerosing cholangitis. Key diagnostic pitfalls, mimics, and structured reporting considerations are discussed, together with emerging quantitative and molecular imaging techniques including diffusion-weighted MRI, dual-energy CT, radiomics, elastography, and fibroblast activation protein inhibitor (FAPI)-based imaging. Recognition of subtle interval morphologic change and discordance from expected inflammatory behaviour is central to earlier detection of IBD-associated malignancy. Careful longitudinal comparison and multidisciplinary correlation remain essential, with radiologists playing a critical role in identifying imaging features that warrant intensified surveillance, tissue sampling, or further intervention.
引用
- Borrero-Leon, Chawla. Imaging manifestations of malignancy in inflammatory bowel disease: patterns, pitfalls and pearls. Abdom Radiol (NY). 2026. PMID: 42663624. doi:10.1007/s00261-026-05717-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。